Home › Juvenile Myelomonocytic Leukemia › District of Columbia
Pag-aaral pangklinika para sa Juvenile Myelomonocytic Leukemia sa District of Columbia
3 pag-aaral para sa Juvenile Myelomonocytic Leukemia ang naghahanap ng mga kalahok sa mga site sa District of Columbia.
Mga Lungsod sa District of Columbia
Opisyal na teksto ng pag-aaral (English)
A Phase I/II Study of Trametinib and Azacitidine for Patients With Newly Diagnosed Juvenile Myelomonocytic Leukemia
- Children's National Medical Center, Washington D.C.
Nagre-recruitPhase 1/2
1 Month – 21 Years · Lahat ng kasarian · Na-update Set 4, 2026 · NCT05849662A Study to Find the Highest Dose of Imetelstat in Combination With Fludarabine and Cytarabine for Patients With AML, MDS or JMML That Has Come Back or Does Not Respond to Therapy
- Children's National Medical Center, Washington D.C.
Nagre-recruitPhase 1
Edad 1 hanggang 18 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT06247787The Pediatric Acute Leukemia (PedAL) Screening Trial - A Study to Test Bone Marrow and Blood in Children With Leukemia That Has Come Back After Treatment or Is Difficult to Treat - A Leukemia & Lymphoma Society and Children's Oncology Group Study
- Children's National Medical Center, Washington D.C.
Nagre-recruitPhase 1/2
Hanggang edad 22 · Lahat ng kasarian · Na-update Ago 25, 2026 · NCT04726241Mula sa ClinicalTrials.gov, na-kuha noong Okt 6, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.